These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16737912

  • 1. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
    Ishii Y, Hsiao HH, Sashida G, Ito Y, Miyazawa K, Kodama A, Ohyashiki JH, Ohyashiki K.
    Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
    [Abstract] [Full Text] [Related]

  • 2. Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).
    Hsiao HH, Sashida G, Ito Y, Kodama A, Fukutake K, Ohyashiki JH, Ohyashiki K.
    Cancer Genet Cytogenet; 2006 Mar; 165(2):161-6. PubMed ID: 16527611
    [Abstract] [Full Text] [Related]

  • 3. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
    Yokoo H, Okada Y, Tominaga K, Tsuji M, Takagi T, Maseki N, Sakurai M, Kaneko Y.
    Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
    [Abstract] [Full Text] [Related]

  • 4. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
    Slovak ML, O'Donnell M, Smith DD, Gaal K.
    Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
    [Abstract] [Full Text] [Related]

  • 5. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
    Sanada M, Uike N, Ohyashiki K, Ozawa K, Lili W, Hangaishi A, Kanda Y, Chiba S, Kurokawa M, Omine M, Mitani K, Ogawa S.
    Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
    [Abstract] [Full Text] [Related]

  • 6. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
    Reddi DM, Lu CM, Fedoriw G, Liu YC, Wang FF, Ely S, Boswell EL, Louissaint A, Arcasoy MO, Goodman BK, Wang E.
    Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
    [Abstract] [Full Text] [Related]

  • 7. [Chromosomal structural changes in patients with myelodysplastic syndrome].
    Yu Y, Liu XP, Liu SH, Yu MH, Zhang Y, Xiao ZJ.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 16; 87(38):2693-7. PubMed ID: 18167247
    [Abstract] [Full Text] [Related]

  • 8. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
    Yamamoto K, Okamura A, Katayama Y, Shimoyama M, Matsui T.
    Leuk Res; 2009 Mar 16; 33(3):377-83. PubMed ID: 18829109
    [Abstract] [Full Text] [Related]

  • 9. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
    Matano S, Kobayashi K, Nakamura S, Yoshida T.
    Rinsho Ketsueki; 1994 Nov 16; 35(11):1310-4. PubMed ID: 7823398
    [Abstract] [Full Text] [Related]

  • 10. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S.
    Int J Hematol; 2017 May 16; 105(5):692-696. PubMed ID: 27914067
    [Abstract] [Full Text] [Related]

  • 11. Deletion of 5q31 and 7q31 in patients with stable melphalan treated multiple myeloma.
    Amiel A, Yukla M, Yogev S, Manor Y, Fejgin MD, Lishner M.
    Cancer Genet Cytogenet; 2004 Jul 01; 152(1):84-7. PubMed ID: 15193449
    [Abstract] [Full Text] [Related]

  • 12. Three cases of multiple myeloma developing into melphalan-related chronic myelomonocytic leukemia.
    Ueki K, Sato S, Tamura J, Sawamura M, Murakami H, Naruse T, Tsuchiya J.
    J Med; 1991 Jul 01; 22(3):157-61. PubMed ID: 1770323
    [Abstract] [Full Text] [Related]

  • 13. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
    Hussain FT, Nguyen EP, Raza S, Knudson R, Pardanani A, Hanson CA, Van Dyke D, Tefferi A.
    Am J Hematol; 2012 Jul 01; 87(7):684-6. PubMed ID: 22565657
    [Abstract] [Full Text] [Related]

  • 14. Secondary myelodysplastic syndrome in multiple myeloma--a study of nine patients with an attempt to detect myeloma patients at risk.
    Mittelman M, Lewinski UH, Weiss H, Cohen AM, Djaldetti M, Pick AI.
    Haematologia (Budap); 1994 Jul 01; 26(2):67-74. PubMed ID: 7890264
    [Abstract] [Full Text] [Related]

  • 15. Leukemic transformation associated with massive hyperdiploidy in myelodysplastic syndrome (MDS) with der(1;7)(q10;p10): a novel case study.
    Lim G, Oh SH, Choi JR, Lee HJ, Suh JT, Yoon HJ, Lee S, Lee WI, Park TS.
    Leuk Res; 2010 Aug 01; 34(8):e208-9. PubMed ID: 20299095
    [No Abstract] [Full Text] [Related]

  • 16. Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation.
    Papaioannou G, Batsis I, Iordanidis F, Vadikoliou C, Kaloyannidis P, Anagnostopoulos A, Athanasiadou A.
    Hematol Oncol; 2011 Sep 01; 29(3):161-3. PubMed ID: 21922511
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.